PCK2 and neoplasm: Enrichment of PCK2 in tumors expressing epithelial markers, and its negative impact on distant metastasis-free survival on an epithelial filtered dataset described here puts weight on the later hypothesis as PEPCK-M activity would favor tumor cell survival while inhibiting entosis.